With human KRAS primers that amplify tumour-derived ctDNA fragments of increasing length up to 409 bp, the highest ctDNA concentrations were obtained for amplicons of length <100 bp and were much higher than the values obtained for mouse (non-tumoral and control) ctDNA. The gene discussed is KRAS; the disease is neoplasm.